thank stand time would like welcome everyone iqvia first quarter earn conference call operator instruction would like turn call senior vice president investor relation treasury please begin conference senior vice president investor relation good morning everyone thank join first quarter earn call today chairman chief executive officer executive vice president chief financial officer executive vice president general counsel child senior vice president financial plan analysis call associate director investor relation succeed today reference presentation visible call webcast presentation also available follow call event presentation section iqvia investor relation website iqvia begin would like caution listener certain information discuss management conference call include forward look statement actual result could differ materially state imply forward look statement risk uncertainty associate company business discuss company file security exchange commission include annual report form subsequent file addition financial measure call consider supplement substitute financial measure prepare accordance reconciliation measure comparable measure include press release conference call presentation would like turn call chairman chairman chief executive morning everyone thank welcome thank join today morning report first quarter result strong double digit growth financial metric result performance improve outlook rest year raise guidance guidance provide last quarter already within reach original plan revise guidance today significantly exceed original plan many reset year company also industry long time traditional timeline development drug long speed vaccine develop obviously raise term expectation crisis accelerate adoption technology believe force last change innovative medicine develop commercialize make iqvia even relevant client highlight power differentiate offer deep client engagement pandemic demonstrate uniquely position bring insight expertise improve drug development commercial timeline also become clear demand many trial slow temporarily push right trial start crowd resolution effort everyone focus demand across therapy area combine record level biotech fund provide strong backdrop industry result favorable condition start process revisit vision goal plan update later year vision progress groundwork next phase journey investor conference later year especially able hold person stay tune information review quarter revenue first quarter grow report basis constant currency million high guidance range half beat come strong operational performance half higher throughs first quarter adjust grow reflect revenue growth productivity measure million beat high guidance range entirely stronger organic revenue performance first quarter adjust dilute grow beat entirely reflect adjust drop little bite color business commercial technology presence continue grow launch offer market quarter pharma client deploy next best action solution country tool base technology platform optimize client sale force effectiveness increase success market activity provide automate sale call recommendation field base advance artificial intelligence machine learn algorithm base rate remain strong another client quarter client deploy user technology platform electronic clinical outcome assessment tool real world also experience strong demand cloud base platform utilize user friendly interface collect clinical data directly patient launch solution strong user acceptance date award study patient million survey complete move continue build strong book momentum business first quarter achieve contract book bill ratio include throughs exclude throughs march contract book bill ratio include throughs exclude throughs number although impressive obviously give strong revenue growth contract backlog include throughs grow year year billion march result next month revenue backlog increase million sequentially billion year year build success experience hybrid virtual trial offer term trial first quarter trial therapeutic area include cardiovascular metabolic disorder work pharma client date recruit almost patient advance trial solution finally complete acquisition remain interest square solution quest diagnostics know square industry lead laboratory service provider clinical trial global capability across safety bioanalytical vaccine genomics bioanalytical test along best class technology specimen consent lifecycle management transaction streamline strategic decision make give flexibility build greater bioanalytical genomic biomarker capability increase attractive growth opportunity expand market turn detail financial performance executive vice president chief financial good morning everyone already mention strong quarter start first give detail revenue first quarter revenue million grow report basis analytics solution revenue first quarter million report constant currency solution first quarter revenue million improve actual rate constant currency revenue tailwind basis point revenue growth rate quarter revenue million report constant currency basis move adjust million quarter margin expand basis point despite significant headwind higher revenue lower margin work income million dilute earn share adjust income million first quarter adjust dilute earn share grow technical issue solution deliver another exceptional quarter business backlog year year billion march next month revenue mention backlog grow significantly currently stand billion year year course metric include first quarter indication momentum business continue beyond year review balance sheet march cash cash equivalent total billion debt billion result debt billion leverage ratio march improve time trail month adjust mark first time since follow merger ratio time particularly noteworthy recall give three year guidance commit delever turn exit please achieve target enter first quarter cash flow free cash flow particular strong cash flow operation million capex million result free cash flow million repurchase million share quarter million share repurchase authorization remain program turn guidance recall back announce acquisition quest interest square joint venture raise guidance reflect elimination quest minority interest joint venture earn wrap revenue adjust guidance unchanged course already consolidate consolidate financial joint venture prior transaction today revise guidance upward follow raise full year revenue guidance high range result increase million midpoint range revenue guidance million million represent year year growth increase guidance range reflect first quarter strength continue operational momentum business also absorb headwind versus previous guidance compare prior year expect tailwind basis point full year revenue growth segment perspective expect full year technology analytics solution revenue grow teen percentage rate solution grow previous expectation revenue business would slightly remain unchanged also raise full year profit guidance result stronger revenue outlook increase increase adjust guidance high range result increase million midpoint full year guidance million million represent year year growth move mention square transaction result raise adjust dilute guidance range raise high guidance range result adjust dilute guidance year year growth move detail interest expense expect approximately million year operational depreciation amortization still expect somewhat million continue assume effective rate approximately full year guidance assume current foreign currency exchange rate remain effect rest year turn second quarter guidance assume rate remain constant quarter second quarter revenue expect million million represent report growth adjust expect million million represent report growth finally adjust dilute expect summarize deliver strong first quarter result report double digit growth financial metric include revenue growth segment backlog improve billion year year next month revenue backlog increase billion year year free cash flow strong quarter leverage improve time trail month adjust finally give strong momentum business raise full year guidance revenue adjust adjust dilute open call like make aware couple leadership change within iqvia finance organization lead investor relation function past four year think agree move become unit child currently corporate function take investor relation corporate communication role three year deep knowledge company financials succeed serve unit past year finally income side know also serve treasurer past couple year corporate controller also assume leadership treasury function forward rest assure stay around finish quarter take question ensure smooth transition hand back open call